Interest in psychedelic molecules is at an all-time high, and debate around the necessity of the subjective effects of hallucinogenic compounds is in full swing.1,2 The stage has been set for psychedelic analogs, compounds that structurally mimic a molecule of interest. With the lights turned on to better therapeutic solutions for mental health and addiction, 18-Methoxycoronaridine (18-MC) has the…


Previous articlePsychedelic Bulletin: Atai Scoops $157m; Efficacy of Microdosing Under Scrutiny; Bright Minds Reduces Bing Eating in Rats
Next articleLobe Sciences Completes Previously Announced Sale of Cannabis Assets to Ionic Brands